Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: Receptor loss in cell culture

Journal of Neuroimmunology

Volumn 189, Issue 1-2, 2007, Pages 111-117

  Sideris, Sotiris ^a   Lagoumintzis, George ^a   Kordas, Gregory ^a   Kostelidou, Kalliopi ^b   Sotiriadis, Alexandros ^b   Poulas, Konstantinos ^a   Tzartos, Socrates J ^a,b  

^a UNIVERSITY OF PATRAS   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Acetylcholine receptor; Antigenic modulation; Autoantibodies; Extracellular domains; Myasthenia gravis

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; COMPLEMENT; IMMOBILIZED ANTIBODY; NICOTINIC RECEPTOR ALPHA; NICOTINIC RECEPTOR BETA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANTIBODY SPECIFICITY; ANTIGENIC MODULATION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE ISOLATION; HUMAN; HUMAN CELL; MALE; MYASTHENIA GRAVIS; PICHIA PASTORIS; PRIORITY JOURNAL; SERUM;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSORBENT TECHNIQUES; MALE; MYASTHENIA GRAVIS; PROTEIN SUBUNITS; RECEPTORS, CHOLINERGIC; RHABDOMYOSARCOMA;

EID: 34447633501     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.06.014     Document Type: Article

References (30)

1. Berrih-Aknin S. Myasthenia gravis, a model of organ-specific autoimmune disease. J. Autoimmun. 8 (1995) 139-143
2. Beeson D., Amar M., Bermudez I., Vincent A., and Newsom-Davis J. Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the epsilon subunit. Neurosci. Lett. 207 (1996) 57-60
3. Cook J.A., and Mitchell J.B. Viability measurements in mammalian cell systems. Anal. Biochem. 179 (1989) 1-7
4. De Baets M., and Stassen M.H. The role of antibodies in myasthenia gravis. J. Neurol. Sci. 202 (2002) 5-11
5. Drachman D.B. Myasthenia gravis. N. Engl. J. Med. 330 (1994) 1797-1810
6. Drachman D.B., Adams R.N., Stanley E.F., and Pestrong A. Mechanisms of acetylcholine receptor loss in myasthenia gravis. J. Neurosurg. Psychiatry 43 (1980) 601-610
7. Fostieri E., Kostelidou K., Poulas K., and Tzartos S. Recent advances in the understanding and therapy of myasthenia gravis. Future Neurol. 1 (2006) 799-817
8. Guyon T., Wakkach A., Poea S., Mouly V., Klingel-Schmitt I., Levasseur P., Beeson D., Asher O., Tzartos S., and Berrih-Aknin S. Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidence for a compensatory mechanism triggered by receptor loss. J. Clin. Invest. 102 (1998) 249-263
9. Heidenreich F., Vincent A., Roberts A., and Newson-Davis J. Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera. Autoimmunity 1 (1988) 285-297
10. Hoch W., Mc Conville J., and Helms S. Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7 (2001) 365-368
11. Jacobson L., Beeson D., Tzartos S., and Vincent A. Monoclonal antibodies raised against human acetylcholine receptor bind to all five subunits of the fetal isoform. J. Neuroimmunol. 98 (1999) 112-120
12. Karlin A. Structure of nicotinic acetylcholine receptors. Curr. Opin. Neurobiol. 3 (1993) 299-309
13. Kostelidou K., Trakas N., Zouridakis M., Bitzopoulou K., Sotiriadis A., Gavra I., and Tzartos S.J. Expression and characterization of soluble forms of the extracellular domains of the beta, gamma, and epsilon subunits of the human muscle acetylcholine receptor. FEBS J. 273 (2006) 3557-3568
14. Lindstrom J.M. Acetylcholine receptors and myasthenia. Muscle Nerve 23 (2000) 453-477
15. Lindstrom J., Einarson B., and Tzartos S. Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 74 (1981) 432
16. Luther M.A., Schopfer R., Whiting P., Casey B., Blatt Y., Montal M.S., Montal M., and Linstrom J. A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J. Neurosci. 9 (1989) 1082-1096
17. Mossman S., Vincent A., and Newsom-Davis J. Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect. J. Neurol. Sci. 84 (1988) 15-28
18. Newsom-Davis J., Pinching A.J., Vincent A., and Wilson S.G. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 28 (1978) 266-272
19. Psaridi-Linardaki L., Mamalaki A., Remoundos M., and Tzartos S.J. Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor α subunit in yeast Pichia pastoris. Role of glycosylation in α-bungarotoxin binding. J. Biol. Chem. 277 (2002) 26980-26986
20. Psaridi-Linardaki L., Trakas N., Mamalaki A., and Tzartos S.J. Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor α-subunit. Development of an antigen-specific therapeutic strategy. J. Neuroimmunol. 159 (2005) 183-191
21. Ragheb S., Mohamed M., and Lisak R.P. Myasthenia gravis patients, but not healthy subjects, recognize epitopes that are unique to the epsilon-subunit of the acetylcholine receptor. J. Neuroimmunol. 159 (2005) 137-145
22. Toyka K.V., Brachman D.B., Pestronk A., and Kao I. Myasthenia gravis: passive transfer from man to mouse. Science 190 (1975) 397-399
23. Toyka K.V., Drachman D.B., Griffin D.E., Pestronk A., Winkelstein J.A., Fishbeck K.H., and Kao I. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N. Engl. J. Med. 296 (1977) 125-131
24. Tzartos S.J., and Lindstrom J.M. Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc. Natl. Acad. Sci. 77 (1980) 755-759
25. Tzartos S.J., Seybold M.E., and Lindstrom J.M. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc. Natl. Acad. Sci. 79 (1982) 188-192
26. Tzartos S., Hochschwender S., Vasquez P., and Lindstrom J. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. J. Neuroimmunol. 15 (1987) 185-194
27. Tzartos S.J., Barkas T., Cung M.T., Mamalaki A., Marraud M., Orlewski P., Papanastasiou D., Sakarelos C., Sakarelos-Daitsiotis M., Tsantili P., and Tsikaris V. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol. Rev. 163 (1998) 89-120
28. Vincent A., Palace J., and Hilton J. Myasthenia gravis. Lancet 357 (2001) 2122-2128
29. Vincent A., Bowen J., Newsom-Davis J., and McConville J. Seronegative generalized myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol. 2 (2003) 99-106
30. Wang Z.Y., Okita D.K., Howard Jr. J., and Conti-Fine B.M. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis. Neurology 50 (1998) 1045-1054